About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

COMPLETED

Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine

Antibody Persistence in Healthy South African Children After Primary Series and Booster Vaccination With an Investigational (DTaP-IPV-Hep B-PRP-T) or Control Vaccines

NCT01105559•Sanofi

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

DiphtheriaTetanusWhooping Cough+2 more

Locations

2

South Africa

Locations (2)

Bertsham, South Africa

Johannesburg, South Africa

Key Dates

Start Date

April 1, 2010

Primary Completion Date

November 1, 2011

Completion Date

December 1, 2011

Last Updated

December 13, 2011

Related Studies

RECRUITINGPhase 1

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

NCT07203755

Diphtheria, Tetanus and Acellular PertussisEpidemic Meningitis+1 more

RECRUITINGPhase 3

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

NCT07112144

Prevent Whooping CoughPrevent Diphtheria+1 more

RECRUITINGPhase 2/3

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

NCT06947499

DiphtheriaTetanus+4 more

Enrolling By InvitationPhase 1

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection

NCT07149454

Active Not Recruiting

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

NCT06258057

Pertussis (Whooping Cough)

Active Not RecruitingPhase 2/3

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

NCT06708286

DiphtheriaTetanus+1 more

View all related studies

Sponsors

Lead Sponsor

Sanofi

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 13, 2011Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions